VJ/OA Oncology Journal Club (Pancreatic Cancer): Nonoperative Management of Technically Resectable Pancreatic Cancer With Ablative Radiation Therapy by Dr. Marsha Reyngold

Cohort study evaluated the use of ablative radiation therapy (A-RT) as a noninvasive alternative to surgery in 25 patients with technically resectable pancreatic ductal adenocarcinoma (PDAC) who were ineligible for surgery due to comorbidities. Conducted at Memorial Sloan Kettering Cancer Center between 2016 and 2022, the study found that A-RT, delivered with high precision and dose intensity, provided promising local control and overall survival, with a 2-year OS rate of 43.7% and manageable toxicity. Despite advanced age, poor performance status, and limited chemotherapy use in the cohort, outcomes suggest A-RT may be a viable local therapy for select patients with resectable PDAC, warranting further prospective investigation.

Link to Arcticle
https://jamanetwork.com/journals/jamaoncology/article-abstract/2832566